SCHEMBL1201554

SCHEMBL1201554

[CH2][C@@H]1CCCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1201578 1.00
SCHEMBL197424 1.00
SCHEMBL4447672 0.92
SCHEMBL4524525 0.89
SCHEMBL3344209 0.81
SCHEMBL3340339 0.81
SCHEMBL197513 0.81
SCHEMBL1099644 0.77
SCHEMBL6264045 0.74
SCHEMBL4811100 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3067355-B1 CRYSTALS OF DIAZABICYCLOOCTANE DERIVATIVE AND PRODUCTION METHOD FOR CRYSTALS OF DIAZABICYCLOOCTANE DERIVATIVE MEIJI SEIKA PHARMA CO LTD (JP) 2020-12-16 EP claimed
CN-111153903-A Crystal of diazabicyclooctane derivative, preparation method and application thereof, and pharmaceutical composition 明治制果药业株式会社 2020-05-15 CN claimed
US-10604522-B2 Processes for producing diazabicyclooctane compounds MEIJI SEIKA PHARMA CO., LTD. (JP) 2020-03-31 US claimed
EP-3613740-A1 PREPARATION OF A DIAZABICYCLOOCTANE DERIVATIVE Meiji Seika Pharma Co., Ltd. (JP) 2020-02-26 EP claimed
EP-3613741-A1 PREPARATION OF A DIAZABICYCLOOCTANE DERIVATIVE Meiji Seika Pharma Co., Ltd. (JP) 2020-02-26 EP claimed
US-20190031659-A1 PROCESSES FOR PRODUCING DIAZABICYCLOOCTANE COMPOUNDS MEIJI SEIKA PHARMA CO., LTD. (JP) 2019-01-31 US claimed
US-10131665-B2 Processes for producing diazabicyclooctane compounds MEIJI SEIKA PHARMA CO., LTD. (JP) 2018-11-20 US claimed
US-20160272641-A1 CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVE AND PRODUCTION PROCESS THEREOF MEIJI SEIKA PHARMA CO., LTD. (JP) 2016-09-22 US claimed
EP-3067355-A1 CRYSTALS OF DIAZABICYCLOOCTANE DERIVATIVE AND PRODUCTION METHOD FOR CRYSTALS OF DIAZABICYCLOOCTANE DERIVATIVE Meiji Seika Pharma Co., Ltd. (JP) 2016-09-14 EP claimed
CN-105612159-A Crystal of diazabicyclooctane derivative and process for producing the same MEIJI SEIKA PHARMA CO LTD 2016-05-25 CN claimed
EP-1863771-A2 BENZAZOLE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE AS B-SECRETASE INHIBITORS Transtech Pharma, Inc. (US) 2007-12-12 EP claimed
US-20060223849-A1 Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors HIGH POINT PHARMACEUTICALS, LLC 2006-10-05 US claimed
WO-2006099379-A2 BENZAZOLE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE AS B-SECRETASE INHIBITORS TRANSTECH PHARMA, INC. (US) 2006-09-21 WO claimed
US-20220348578-A1 CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVE AND PRODUCTION PROCESS THEREOF MEIJI SEIKA PHARMA CO., LTD. (JP) 2022-11-03 US disclosed
WO-2021132422-A1 PYRIDAZINYL THIAZOLECARBOXAMIDE COMPOUND アステラス製薬株式会社 2021-07-01 WO disclosed
EP-3067355-B1 CRYSTALS OF DIAZABICYCLOOCTANE DERIVATIVE AND PRODUCTION METHOD FOR CRYSTALS OF DIAZABICYCLOOCTANE DERIVATIVE MEIJI SEIKA PHARMA CO LTD (JP) 2020-12-16 EP disclosed
EP-1487806-A1 4-ANILINO QUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE AGENTS Astrazeneca AB (SE) 2004-12-22 EP disclosed
WO-2003082831-A1 4-ANILINO QUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE AGENTS ASTRAZENECA AB (SE) 2003-10-09 WO disclosed
EP-1302458-A1 ESTER DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2003-04-16 EP disclosed
CN-1188484-A Compounds with growth hormone releasing properties NOVO NORDISK AS (DK) 1998-07-22 CN disclosed